HomeCompareLSB vs BTI

LSB vs BTI: Dividend Comparison 2026

LSB yields 318.98% · BTI yields 5.40%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LSB wins by $2296.48M in total portfolio value
10 years
LSB
LSB
● Live price
318.98%
Share price
$0.63
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2296.51M
Annual income
$1,420,493,114.32
Full LSB calculator →
BTI
BTI
● Live price
5.40%
Share price
$58.26
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.8K
Annual income
$2,802.29
Full BTI calculator →

Portfolio growth — LSB vs BTI

📍 LSB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLSBBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LSB + BTI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LSB pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LSB
Annual income on $10K today (after 15% tax)
$27,113.24/yr
After 10yr DRIP, annual income (after tax)
$1,207,419,147.17/yr
BTI
Annual income on $10K today (after 15% tax)
$459.05/yr
After 10yr DRIP, annual income (after tax)
$2,381.95/yr
At 15% tax rate, LSB beats the other by $1,207,416,765.23/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LSB + BTI for your $10,000?

LSB: 50%BTI: 50%
100% BTI50/50100% LSB
Portfolio after 10yr
$1148.28M
Annual income
$710,247,958.30/yr
Blended yield
61.85%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

LSB
No analyst data
Altman Z
-2.7
Piotroski
2/9
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.3% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LSB buys
0
BTI buys
0
No recent congressional trades found for LSB or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLSBBTI
Forward yield318.98%5.40%
Annual dividend / share$2.00$3.15
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%11.3%
Portfolio after 10y$2296.51M$37.8K
Annual income after 10y$1,420,493,114.32$2,802.29
Total dividends collected$2210.37M$14.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: LSB vs BTI ($10,000, DRIP)

YearLSB PortfolioLSB Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$42,598$31,897.93$11,301$601.08+$31.3KLSB
2$172,569$126,989.30$12,799$706.58+$159.8KLSB
3$665,442$480,792.73$14,527$832.38+$650.9KLSB
4$2,444,714$1,732,690.93$16,527$982.75+$2.43MLSB
5$8,564,999$5,949,155.42$18,846$1,162.95+$8.55MLSB
6$28,643,738$19,479,189.22$21,545$1,379.49+$28.62MLSB
7$91,530,880$60,882,080.00$24,694$1,640.41+$91.51MLSB
8$279,758,876$181,820,834.73$28,378$1,955.69+$279.73MLSB
9$818,711,097$519,369,100.17$32,702$2,337.79+$818.68MLSB
10$2,296,513,989$1,420,493,114.32$37,794$2,802.29+$2296.48MLSB

LSB vs BTI: Complete Analysis 2026

LSBStock

LakeShore Biopharma Co., Ltd, a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was formerly known as YS Biopharma Co., Ltd. and changed its name to LakeShore Biopharma Co., Ltd in May 2024. LakeShore Biopharma Co., Ltd was founded in 2002 and is based in Beijing, China.

Full LSB Calculator →

BTIConsumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this LSB vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LSB vs SCHDLSB vs JEPILSB vs OLSB vs KOLSB vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.